scanance.
Sign inGet Premium
CT

CTEV

CTEVHealthcareNASDAQ

Health Information Services · Last scanned May 30, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$965.4M
+3.7% YoY
Net Income
-$284.3M
+82.7% YoY
EBITDA
$467.4M
+146.4% YoY
Free Cash Flow
$108.9M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About CTEV

Operating under the Health Information Services umbrella, CTEV is a healthcare company. Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in. The company carries a $428.2M market cap, placing it firmly in the small-cap category. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.

Key stats
Market Cap$428.2M
Fwd P/E3.67
EPS$-17.33
Beta0.77
52W Change-34.3%
Analysis

CTEV carries $4.74B in total debt against $21.3M in cash reserves — debt is roughly 222.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $108.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROA of 1.1% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $1.08B (2022) to $965.4M (2025), a 11% decline worth watching.

CTEV carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence CTEV's trajectory.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms